Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
ArticlesFull Access

Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial

Published Online:15 Jul 2016https://doi.org/10.1176/appi.ajp.2016.15070967

References

  • 1 Kessler RC, Sonnega A, Bromet E, et al.: Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52:1048–1060 Crossref, Medline, Google Scholar
  • 2 Hoge CW, Castro CA, Messer SC, et al.: Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004; 351:13–22 Crossref, Medline, Google Scholar
  • 3 American Psychiatric Association: Diagnostic and Statistic Manual for Mental Disorders, 5th ed. Washington, DC, APA, 2013 Crossref, Google Scholar
  • 4 Hamner MB: Psychotic features and combat-associated PTSD. Depress Anxiety 1997; 5:34–38 Crossref, Medline, Google Scholar
  • 5 David D, Kutcher GS, Jackson EI, et al.: Psychotic symptoms in combat-related posttraumatic stress disorder. J Clin Psychiatry 1999; 60:29–32 Crossref, Medline, Google Scholar
  • 6 Hamner MB, Frueh BC, Ulmer HG, et al.: Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis 2000; 188:217–221 Crossref, Medline, Google Scholar
  • 7 Foa EB, Keane TM, Friedman MJ, et al.: Effective Treatments for PTSD: Practice Guidelines From the International Society for Traumatic Stress Studies. New York, Guilford Press, 2008 Google Scholar
  • 8 van der Kolk BA, Dreyfuss D, Michaels M, et al.: Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994; 55:517–522 Medline, Google Scholar
  • 9 Hertzberg MA, Feldman ME, Beckham JC, et al.: Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 2000; 12:101–105 Crossref, Medline, Google Scholar
  • 10 Zohar J, Amital D, Miodownik C, et al.: Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 2002; 22:190–195 Crossref, Medline, Google Scholar
  • 11 Cañive JM, Clark RD, Calais LA, et al.: Bupropion treatment in veterans with posttraumatic stress disorder: an open study. J Clin Psychopharmacol 1998; 18:379–383 Crossref, Medline, Google Scholar
  • 12 Hamner MB, Faldowski RA, Ulmer HG, et al.: Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 2003; 18:1–8 Crossref, Medline, Google Scholar
  • 13 Hamner MB, Robert S, Frueh BC: Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectr 2004; 9:740–752 Crossref, Medline, Google Scholar
  • 14 Villarreal G, Calais LA, Cañive JM, et al.: Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Psychopharmacol Bull 2007; 40:6–18 Medline, Google Scholar
  • 15 Stein MB, Kline NA, Matloff JL: Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 2002; 159:1777–1779 Link, Google Scholar
  • 16 Carey P, Suliman S, Ganesan K, et al.: Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol 2012; 27:386–391 Crossref, Medline, Google Scholar
  • 17 Ahearn EP, Juergens T, Cordes T, et al.: A review of atypical antipsychotic medications for posttraumatic stress disorder. Int Clin Psychopharmacol 2011; 26:193–200 Medline, Google Scholar
  • 18 Krystal JH, Rosenheck RA, Cramer JA, et al.: Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA 2011; 306:493–502 Crossref, Medline, Google Scholar
  • 19 Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 2000; 68:29–39 Crossref, Medline, Google Scholar
  • 20 Nikisch G, Baumann P, Liu T, et al.: Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response. Int J Neuropsychopharmacol 2012; 15:1051–1061 Crossref, Medline, Google Scholar
  • 21 López-Muñoz F, Alamo C: Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders. Front Psychiatry 2013; 4:102 Crossref, Medline, Google Scholar
  • 22 Hamner MB, Deitsch SE, Brodrick PS, et al.: Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol 2003; 23:15–20 Crossref, Medline, Google Scholar
  • 23 Robert S, Hamner MB, Kose S, et al.: Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study. J Clin Psychopharmacol 2005; 25:387–388 Crossref, Medline, Google Scholar
  • 24 Byers MG, Allison KM, Wendel CS, et al.: Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol 2010; 30:225–229 Crossref, Medline, Google Scholar
  • 25 Department of Veterans Affairs and Department of Defense: VA/DoD Clinical Practice Guideline for the Management of Post-Traumatic Stress, 2010 ( http://www.healthquality.va.gov/guidelines/MH/ptsd/cpgPTSDFULL201011612c.pdf) Google Scholar
  • 26 Blake DD, Weathers FW, Nagy LM, et al.: The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8:75–90 Crossref, Medline, Google Scholar
  • 27 First MB, Spitzer RL, Gibbon M, et al.: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York, New York State Psychiatric Institute, Biometrics Research, 2002 Google Scholar
  • 28 Bauer MS, Lee A, Li M, et al.: Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates. Pharmacoepidemiol Drug Saf 2014; 23:77–86 Crossref, Medline, Google Scholar
  • 29 Hermes E, Sernyak M, Rosenheck R: The use of second generation antipsychotics for post-traumatic stress disorder in a US Veterans Health Administration Medical Center. Epidemiol Psychiatr Sci 2014; 23:281–288 Crossref, Medline, Google Scholar
  • 30 Thase ME: Quetiapine monotherapy for bipolar depression. Neuropsychiatr Dis Treat 2008; 4:11–21 Medline, Google Scholar
  • 31 Mohamed S, Rosenheck RA: Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. J Clin Psychiatry 2008; 69:959–965 Crossref, Medline, Google Scholar
  • 32 Raskind MA, Peterson K, Williams T, et al.: A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry 2013; 170:1003–1010 Link, Google Scholar
  • 33 Hamner MB, Arvanitis LA, Miller BG, et al.: Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636). Psychopharmacol Bull 1996; 32:107–110 Medline, Google Scholar
  • 34 Benedek DM, Friedman MJ, Zatzick D, Ursano RJ: Guideline Watch (March 2009): Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. ( http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd-watch.pdf) Google Scholar
  • 35 Newcomer JW: Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007; 68(suppl 4):8–13 Crossref, Medline, Google Scholar